Common peroneal and ulnar nerves of 21 dogs between 2 and 15 years of age with malignant tumors were examined for possible paraneoplastic effects. Percent of abnormalities in single-teased fiber studies exceeded the confidence limits (P = 0.99) established for age-matched control dogs in 16 of 21 dogs (76%) with malignancies, none of which manifested clinical signs of polyneuropathy. The incidence of abnormalities was higher in commmon peroneal nerve (73%) than in ulnar nerve (57%). Lesions were characterized by a mixture of demyelination/remyelination and axonal degeneration; however, the former lesions predominated in most affected dogs. The severity of the neuropathy varied with different tumors, with the most severe lesions observed in a bronchogenic carcinoma (59%), a mammary adenocarcinoma (59%), a malignant melanoma (48%), and an insulinoma (47%).
References
1.
BradleyWGLassmanLPPearceGWWaltonJN:
The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies.J Neurol Sci10:
107,
1970
2.
BraundKG:
Neurologic Syndromes in Veterinary Neurology,
p. 149.
Williams & Wilkins,
Baltimore,1986
3.
BraundKGDillonARMikealRLAugustJR:
Subclinical myopathy associated with hyperadrenocorticism in the dog.Vet Pathol17:
134,
1980
4.
BraundKGMcGuireJALincolnCE:
Age-related changes in peripheral nerves of the dog. I. A morphologic and morphometric study of single-teased fibers.Vet Pathol19:
365,
1982
5.
BraundKGMcGuireJALincolnCE:
Age-related changes in peripheral nerves of the dog. II. A morphologic and morphometric study of cross-sectional nerve.Vet Pathol19:
379,
1982
6.
BraundKGSteissJE:
Distal neuropathy in spontaneous diabetes mellitus in the dog.Acta Neuropathol57:
263,
1982
7.
CoatesASCarnegiePR:
Immunological cross-reactivity between basic proteins of myelin and cancer. I. Lymphocyte transformation studies in immunized guineapigs.Clin Exp Immunol22:
16,
1975
8.
CroftPBWilkinsonMIP:
Carcinomatous neuromyopathy. Its incidence in patients with carcinoma of the lung and carcinoma of the breast.Lanceti:
184,
1963
9.
CroftPBWilkinsonMIP:
The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma.Brain88:
427,
1965
10.
DyckPJ:
Pathologic alterations of the peripheral nervous system of man. In:
Peripheral Neuropathy,
ed. DyckPJThomasPKLambertEHBungeR,
2nd ed.,
vol. II,
p. 296.
Saunders Company,
Philadelphia,1984
11.
Estable-PuigJFBauerWCBlumbergJM:
Paraphenylene diamine staining of osmium-fixed plastic embedded tissue for light and phase microscopy.J Neuropathol Exp Neurol24:
531,
1965
12.
FieldEJCasparyEA:
Lymphocyte sensitization: an in vitro test for cancer?Lancetii:
1337,
1970
13.
FlavellDJGoepelJWilsonAPPotterCW:
Immunological cross-reactivity between acid extracts of myelin, liver and neoplastic tissues: studies in immunized guinea pigs.Br J Cancer40:
424,
1979
14.
GottschalkPGDyckPJKielyJM:
Vinca alkaloid neuropathy: nerve biopsy studies in rats and man.Neurology18:
875,
1968
15.
GriffithsIRDuncanIDSwallowJS:
Peripheral neuropathies in dogs: a study of five cases.J Small Anim Pract18:
101,
1977
16.
HansonMR:
Paraneoplastic syndrome: clinical aspects. In:
Neuromuscular Complications of Cancer, Proceedings of Eighth Annual Continuing Education Course,
p. 21,
Las Vegas, Nevada, October 24,
1985
17.
HensenRAUrichH:
Cancer and the Nervous System,
p. 368.
Blackwell Scientific Publications,
Oxford,1982
18.
KudoMNoguchiT:
Immunoreactive myelin basic protein in tumor cells associated with carcinomatous neuropathy.Am J Clin Pathol84:
741,
1985
19.
McLeodJG:
Carcinomatous neuropathy. In:
Peripheral Neuropathy,
ed. DyckPJThomasPKLambertEHBungeR,
2nd ed.,
vol. II,
pp. 2,
180.
Saunders Company,
Philadelphia,1984
20.
MendellJRSahenkZWhitakerJNTrappBDYatesAJGriggsRCQuarlesRH:
Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody.Ann Neurol17:
243,
1985
21.
MoodyJF:
Electrophysiological investigations in the neurological complications of carcinoma.Brain88:
1023,
1965
22.
PearseAGE:
The diffuse neuroendocrine system and the APUD concept: related “endocrine“ peptides in brain, intestine, pituitary, placenta, and anuran cutaneous glands.Med Biol55:
115,
1977
23.
ReddingRWBraundKG:
Neurologic examination. In:
Canine Neurology—Diagnosis and Treatment,
ed. HoerleinBF,
3rd ed.,
p. 53.
Saunders Company,
Philadelphia,1978
24.
SorjonenDCBraundKGHoffEJ:
Paraplegia and subclinical neuromyopathy associated with a primary lung tumor in a dog.J Am Vet Med Assoc180:
1209,
1982
25.
StollBAAndrewsJT:
Radiation-inducted peripheral neuropathy.Br Med J1:
834,
1966
26.
TeravainenHLarsenA:
Some features of the neuromuscular complications of pulmonary carcinoma.Ann Neurol2:
495,
1977
27.
TrojaborgWFrantzenEAndersonI:
Peripheral neuropathy and myopathy associated with carcinoma of the lung.Brain92:
71,
1969
28.
TylerHR:
Paraneoplastic syndromes of nerve, muscle and neuromuscular junction.Ann NY Acad Sci230:
348,
1974
29.
VisserPAFriesenSR:
Uncommon tumors of the APUD system.Surg Clin N Am59:
143,
1979
30.
WhelanHT:
Neuromuscular syndromes associated with cancer.Compreh Ther11:
50,
1985
31.
WilkinsonPCZeromskiJ:
Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy.Brain88:
529,
1965
